8-K
Current Report
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-005787
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading cns_8k.htm…